This topic contains a solution. Click here to go to the answer

Author Question: A client received mivacurium (Mivacron) for a surgical procedure. Which assessment findings indicate ... (Read 69 times)

Shelles

  • Hero Member
  • *****
  • Posts: 582
A client received mivacurium (Mivacron) for a surgical procedure. Which assessment findings indicate adverse effects of this medication?
 
  Standard Text: Select all that apply.
  1. Bradycardia
  2. Hypotension
  3. Increased heart rate
  4. Decreased heart rate
  5. Hyperactive bowel sounds

Question 2

A client is scheduled for surgery to repair an abdominal aortic aneurysm. Which neuromuscular blocking agents will be the best choice for this client?
 
  Standard Text: Select all that apply.
  1. Tubocurarine
  2. Mivacurium (Mivacron)
  3. Pancuronium (Pavulon)
  4. Vecuronium (Norcuron)
  5. Succinylcholine (Anectine)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Melissahxx

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

Correct Answer: 1,2,3,4
Rationale 1: Bradycardia is an adverse effect of this medication.
Rationale 2: Hypotension is an adverse effect of this medication.
Rationale 3: Increased heart rate is an adverse effect of this medication.
Rationale 4: Decreased heart rate is an adverse effect of this medication.
Rationale 5: Hyperactive bowels sounds are not an adverse effect of this medication.
Global Rationale: Bradycardia, hypotension, increased heart rate, and decreased heart rate are adverse effects of this medication. Hyperactive bowels sounds are not an adverse effect of this medication.

Answer to Question 2

Correct Answer: 1,2,3,4
Rationale 1: Tubocurarine is used as an adjunct to anesthesia to cause complete skeletal muscle relaxation of the abdominal muscles during operative procedures.
Rationale 2: This is a short-acting nondepolarizing neuromuscular blocking agent that can be used as a continuous infusion for this surgical procedure.
Rationale 3: This is an intermediate-acting nondepolarizing neuromuscular blocking agent that can be used for this surgical procedure.
Rationale 4: This is an intermediate-acting nondepolarizing neuromuscular blocking agent that can be used for this surgical procedure.
Rationale 5: This is a depolarizing neuromuscular blocking agent that is used for short procedures and would not be indicated for an abdominal aortic aneurysm repair.
Global Rationale: Tubocurarine is used as an adjunct to anesthesia to cause complete skeletal muscle relaxation of the abdominal muscles during operative procedures. Mivacurium (Mivacron) is a short-acting nondepolarizing neuromuscular blocking agent that can be used as a continuous infusion for this surgical procedure. Pancuronium (Pavulon) is an intermediate-acting nondepolarizing neuromuscular blocking agent that can be used for this surgical procedure. Vecuronium (Norcuron) is an intermediate-acting nondepolarizing neuromuscular blocking agent that can be used for this surgical procedure. Succinylcholine (Anectine) is a depolarizing neuromuscular blocking agent that is used for short procedures and would not be indicated for an abdominal aortic aneurysm repair.




Shelles

  • Member
  • Posts: 582
Reply 2 on: Jul 23, 2018
Excellent


zacnyjessica

  • Member
  • Posts: 345
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

The word drug comes from the Dutch word droog (meaning "dry"). For centuries, most drugs came from dried plants, hence the name.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

For a complete list of videos, visit our video library